Estradiol Suppression for the Treatment of Metastatic Breast Cancer in Premenopausal Women

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 31, 2000

Primary Completion Date

May 31, 2013

Study Completion Date

June 30, 2013

Conditions
Breast Cancer
Interventions
DRUG

Anastrozole (Arimidex)

Anastrozole is a prescription hormonal treatment that helps fight breast cancer by lowering the amount of estrogen in the body. It is a non-steroidal aromatase inhibitor, which significantly lowers serum estradiol (estrogen) concentrations, without interfering with the formation of adrenal corticosteroids or aldosterone

DRUG

Goserelin (Zoladex)

Goserelin is a palliative treatment of advanced breast cancer in pre- and perimenopausal women

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

Stanford University

OTHER